Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518316 | 0.91 | — | — | |
| SCHEMBL31210100 | 0.87 | CES1 (0.36) | CES1 | |
| SCHEMBL29838355 | 0.84 | CES1 (0.31) | CES1 | |
| SCHEMBL9411720 | 0.84 | CES1 (0.31) | CES1 | |
| SCHEMBL29838385 | 0.84 | CES1 (0.31) | CES1 | |
| SCHEMBL29838517 | 0.82 | CES1 (0.32) | CES1 | |
| SCHEMBL18092846 | 0.82 | CYP1A2 (0.34) | — | |
| SCHEMBL6859937 | 0.80 | — | — | |
| SCHEMBL2550393 | 0.80 | — | — | |
| SCHEMBL29398265 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0611771-A1 | Destructible fluorinated alkoxysilane surfactants and repellent coatings derived therefrom | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-08-24 | — | — | EP | claimed |
| US-5274159-A | Hydrophilic and hydrophobic; hydrolysis | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-12-28 | — | — | US | claimed |
| WO-2024141628-A1 | VARIABLE VISCOSITY INKS FOR INKJET DELIVERY OF ENZYME REAGENTS | DNA SCRIPT (FR) | 2024-07-04 | — | — | WO | disclosed |
| US-20230313255-A1 | Massively Parallel Enzymatic Synthesis of Polynucleotides | DNA SCRIPT (FR) | 2023-10-05 | — | — | US | disclosed |
| US-20230180747-A1 | NONWOVEN FIBROUS WEBS AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION | 2023-06-15 | — | — | US | disclosed |
| US-8753811-B2 | Method for making populations of defined nucleic acid molecules | COLD SPRING HARBOR LABORATORY (US) | 2014-06-17 | — | — | US | disclosed |
| US-8546130-B2 | Microarray comprising cell active regions for use as tool in gene expression profiling, genotyping and detection of mutations and/or polymorphisms | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-10-01 | — | — | US | disclosed |
| US-20120208723-A1 | OLIGOMER PROBE ARRAY WITH IMPROVED SIGNAL-TO-NOISE RATIO AND DETECTION SENSITIVITY AND METHOD OF MANUFACTURING THE SAME | HAH JUNG-HWAN (KR) | 2012-08-16 | — | — | US | disclosed |
| US-20120149602-A1 | METHOD FOR MAKING POPULATIONS OF DEFINED NUCLEIC ACID MOLECULES | COLD SPRING HARBOR LABORATORY | 2012-06-14 | — | — | US | disclosed |
| US-8133670-B2 | Method for making populations of defined nucleic acid molecules | COLD SPRING HARBOR LABORATORY (US) | 2012-03-13 | — | — | US | disclosed |
| US-20100113287-A1 | METHODS FOR ASSESSING THE REPRESENTATION OF NUCLEIC ACID MOLECULES IN A NUCLEIC ACID LIBRARY | ROSETTA INPHARMATICS LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-6335098-B1 | Rotary press doctor | KOENIG & BAUER AKTIENGESELLSCHAFT (DE) | 2002-01-01 | — | — | US | disclosed |
| US-6289807-B1 | Open, pressureless ink duct having a low surface energy coating to aid in forming a roll of ink | KOENIG & BAUER AKTIENGESELLSCHAFT (DE) | 2001-09-18 | — | — | US | disclosed |
| US-20010018512-A1 | Chemical synthesis using solvent microdroplets | UNIVERSITY OF WASHINGTON | 2001-08-30 | — | — | US | disclosed |
| EP-1114314-A1 | DEVICE COMPRISING A PLURALITY OF ANALYSIS SITES ON A SUPPORT | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2001-07-11 | — | — | EP | disclosed |
| EP-0934164-B1 | ROTARY PRESS DOCTOR | KOENIG & BAUER AG (DE) | 2000-12-27 | — | — | EP | disclosed |
| EP-0934166-B1 | INK DUCT | KOENIG & BAUER AG (DE) | 2000-04-26 | — | — | EP | disclosed |
| WO-2000016082-A1 | DEVICE COMPRISING A PLURALITY OF ANALYSIS SITES ON A SUPPORT | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2000-03-23 | — | — | WO | disclosed |
| EP-0970101-A2 | SOLVENT FOR BIOPOLYMER SYNTHESIS, SOLVENT MICRODROPLETS AND METHODS OF USE | UNIVERSITY OF WASHINGTON (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041531-A2 | SOLVENT FOR BIOPOLYMER SYNTHESIS, SOLVENT MICRODROPLETS AND METHODS OF USE | UNIVERSITY OF WASHINGTON (US) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018512-A1 | Chemical synthesis using solvent microdroplets | SUB1, MSN, SRM | CES1 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.